Contact Sales

-9th May 2012

Mirada Medical Wins Software Sale for Radiotherapy Cancer Research at the Gray Institute

Oxford, United Kingdom, 7 May, 2012: Mirada Medical, a leading innovator in medical imaging analysis software, announced that the Gray Institute for Radiation Oncology and Biology has selected the company’s powerful RTx software for use in their research and clinical trials. The Gray Institute has been created to be the world’s largest and most comprehensive centre for research in radiation oncology and biology and is located in Oxford, England. Mirada will be demonstrating the latest version of the RTx suite at the annual European Society of Radiotherapy and Oncology (ESTRO) meeting, booth #4400, 9th-12th May Barcelona, Spain. Mirada RTx provides tools to support dose warping and summation, atlas based contouring, multi-modal fusion and adaptive therapy. The addition of Mirada software tools will allow the Gray Institute to perform sophisticated analysis and manipulate large amounts of data for cutting edge research into new cancer treatments. “We are delighted that Mirada RTx has been selected by the prestigious Gray Institute for Radiation Oncology and Biology,” explained Timor Kadir, Chief Science Officer for Mirada Medical. “RTx gives Gray Institute the tools needed to answer questions around treatment and response to therapy that were previously very time consuming or difficult to investigate. It also allows them to produce contour sets for use in treatment plans in an efficient manner, thus freeing up time and resources to do other important tasks.”